2011
DOI: 10.1038/aps.2011.57
|View full text |Cite
|
Sign up to set email alerts
|

Current understanding of KATP channels in neonatal diseases: focus on insulin secretion disorders

Abstract: ATP-sensitive potassium (K ATP ) channels are cell metabolic sensors that couple cell metabolic status to electric activity, thus regulating many cellular functions. In pancreatic beta cells, K ATP channels modulate insulin secretion in response to fluctuations in plasma glucose level, and play an important role in glucose homeostasis. Recent studies show that gain-of-function and loss-of-function mutations in K ATP channel subunits cause neonatal diabetes mellitus and congenital hyperinsulinism respectively. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
0
2

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 218 publications
0
27
0
2
Order By: Relevance
“…Calcium influx triggers insulin release from b cells (Ashcroft, 2006;Nichols, 2006). Moreover, genetic mutations of genes encoding K ATP subunits cause diseases, such as neonatal diabetes, hyperinsulinism, DEND syndrome, and Cantú syndrome (Nichols, 2006;Quan et al, 2011), manifesting that K ATP channels are important therapeutic targets. K ATP channel inhibitors, such as sulfonylureas, are widely used for treating type II diabetes, while K ATP channel activators, such as potassium channel openers, are used for treating hyperinsulinism and have shown great promise for myoprotection (Flagg et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Calcium influx triggers insulin release from b cells (Ashcroft, 2006;Nichols, 2006). Moreover, genetic mutations of genes encoding K ATP subunits cause diseases, such as neonatal diabetes, hyperinsulinism, DEND syndrome, and Cantú syndrome (Nichols, 2006;Quan et al, 2011), manifesting that K ATP channels are important therapeutic targets. K ATP channel inhibitors, such as sulfonylureas, are widely used for treating type II diabetes, while K ATP channel activators, such as potassium channel openers, are used for treating hyperinsulinism and have shown great promise for myoprotection (Flagg et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…As such, mutations in KATP that affect its response to changes in cellular metabolism cause diseases of insulin secretion, e.g. neonatal diabetes and persistent hyperinsulinemic hypoglycaemia of infancy (PHHI; (Quan et al, 2011;Ashcroft et al, 2017)).…”
Section: Introductionmentioning
confidence: 99%
“…In pancreatic beta-cells, KATP channels regulate the secretion of insulin. 9 With regard to structure, KATP channels, as large hetero-octameric complexes include four regulatory sulphonylurea receptors (SURx) and four pore-forming (Kir6.x) (via cytoplasmic domains bind to ATP) subunits, which are encoded by ABCC8 and KCNJ11, respectively. 10,11 Considering the KATP channel activity, the membrane is held at a hyperpolarized level that results in voltage-gated Ca2+ channels' closure.…”
Section: Atp-sensitive Potassium Channelmentioning
confidence: 99%